Odegard Valerie
SEC CIK 1832432 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Pres, CSO | 61.6K | — | — | 2 | 2022-02-01 | 2022-05-02 |
Most active insiders at SPRY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chakma Justin | Chief Business Off | — | $1.48M |
| 2 | Karas Eric | Chief Commercial Off | — | $250.0K |
| 3 | Dorsey Brian | COO | — | $190.1K |
| 4 | Fitzpatrick Alexander A | CLO | — | $33.5K |
| 5 | Shah Pratik | Dir | — | — |
Odegard Valerie made no open-market trades at SPRY in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-04 | 2022-05-02 | SPRY | ARS Pharmaceuticals, Inc. | Odegard Valerie | Pres, CSO | A - Grant | $0.00 | +45.2K | 61.6K | +276% | $0 |
| D | 2022-02-02 | 2022-02-01 | SPRY | ARS Pharmaceuticals, Inc. | Odegard Valerie | Pres, CSO | A - Grant | $0.00 | +16.4K | 16.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations